Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrel...
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial
About this item
Full title
Author / Creator
StarMS trial team , Brittain, Gavin , Petrie, Jennifer , Duffy, Kate E M , Glover, Rachel , Hullock, Katie , Papaioannou, Diana , Roldan, Elisa , Beecher, Colette , Bursnall, Matthew , Ciccarelli, Olga , Coles, Alasdair J , Cooper, Cindy , Giovannoni, Gavin , Gabriel, Ian , Kazmi, Majid , Kyriakou, Charalampia , Nicholas, Richard , Paling, David , Peniket, Andy , Scolding, Neil , Silber, Eli , de Silva, Thushan , Venneri, Annalena , Walters, Stephen J , Young, Carolyn , Muraro, Paolo A , Sharrack, Basil , Snowden, John A , Publicover, Amy , Clark, Andy , Ismail, Azza , Turner, Ben , Besley, Caroline , Kyriakou, Charalampia , Crawley, Charles , Rice, Claire , Hunt, David , Rog, David , Tholouli, Eleni , Nikfekr, Esmaeil , Kinsella, Fran , Luca, Gabriele De , Mazibrada, Gordon , Hunter, Hannah , Galea, Ian , Pomeroy, Ian , Davies, Jeff , Byrne, Jenny , Hobart, Jeremy , Campbell, Keith , Orchard, Kim , Finisku, Leonora , Duddy, Martin , Vinjam, Maruthi , Saif, Muhammad , Robertson, Neil , Ciccarelli, Olga , Gallagher, Paul , Bulley, Simon and Campbell, Vic
Publisher
England: British Medical Journal Publishing Group
Journal title
Language
English
Formats
Publication information
Publisher
England: British Medical Journal Publishing Group
Subjects
More information
Scope and Contents
Contents
IntroductionAutologous haematopoietic stem cell transplantation (aHSCT) is increasingly used as treatment for patients with active multiple sclerosis (MS), typically after failure of disease-modifying therapies (DMTs). A recent phase III trial, ‘Multiple Sclerosis International Stem Cell Transplant, MIST’, showed that aHSCT resulted in prolonged ti...
Alternative Titles
Full title
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Brittain, Gavin
Petrie, Jennifer
Duffy, Kate E M
Glover, Rachel
Hullock, Katie
Papaioannou, Diana
Roldan, Elisa
Beecher, Colette
Bursnall, Matthew
Ciccarelli, Olga
Coles, Alasdair J
Cooper, Cindy
Giovannoni, Gavin
Gabriel, Ian
Kazmi, Majid
Kyriakou, Charalampia
Nicholas, Richard
Paling, David
Peniket, Andy
Scolding, Neil
Silber, Eli
de Silva, Thushan
Venneri, Annalena
Walters, Stephen J
Young, Carolyn
Muraro, Paolo A
Sharrack, Basil
Snowden, John A
Publicover, Amy
Clark, Andy
Ismail, Azza
Turner, Ben
Besley, Caroline
Kyriakou, Charalampia
Crawley, Charles
Rice, Claire
Hunt, David
Rog, David
Tholouli, Eleni
Nikfekr, Esmaeil
Kinsella, Fran
Luca, Gabriele De
Mazibrada, Gordon
Hunter, Hannah
Galea, Ian
Pomeroy, Ian
Davies, Jeff
Byrne, Jenny
Hobart, Jeremy
Campbell, Keith
Orchard, Kim
Finisku, Leonora
Duddy, Martin
Vinjam, Maruthi
Saif, Muhammad
Robertson, Neil
Ciccarelli, Olga
Gallagher, Paul
Bulley, Simon
Campbell, Vic
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_cef35258b9e74bbbaf15d925d8681e1d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cef35258b9e74bbbaf15d925d8681e1d
Other Identifiers
ISSN
2044-6055
E-ISSN
2044-6055
DOI
10.1136/bmjopen-2023-083582
